Windtree Therapeutics announces resale of 42.17M shares by selling stockholders
Source: SeekingAlpha
2025-05-16 16:25:10 ET
More on Windtree Therapeutics
- Windtree Therapeutics regains compliance with Nasdaq listing rules
- Windtree shares rise as it announces agreement to become sourcing partner for Evofem
- Seeking Alpha’s Quant Rating on Windtree Therapeutics
- Historical earnings data for Windtree Therapeutics
- Financial information for Windtree Therapeutics
Read the full article on Seeking Alpha
For further details see:
Windtree Therapeutics announces resale of 42.17M shares by selling stockholders
Windtree Therapeutics Inc.
NASDAQ: WINT
WINT Trading
-12.12% G/L:
$0.116 Last:
1,921,610 Volume:
$0.132 Open:
WINT Latest News
December 23, 2025 09:00:00 am
Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates
December 03, 2025 09:00:00 am
Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space
November 17, 2025 09:00:00 am
Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee
November 14, 2025 09:00:00 am
Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate
WINT Stock Data
$286,525
33,371,696
0.1%
15
1134204%
Biotechnology & Life Sciences
Healthcare
US
Warrington
